Telix Pharmaceuticals Limited (TLX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.90B and a free-cash-flow yield of -1.6%. Over the most recent reported fiscal year, revenue grew 55.6% and free cash flow per share fell 1327.3%.